Greenwood Capital Associates LLC Merck & Co., Inc. Transaction History

Greenwood Capital Associates LLC

$755 Million
Q3 2024

A detailed history of Greenwood Capital Associates LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 1,926 shares of MRK stock, worth $192,715. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,926

Previous 14,231 86.47%

Holding current value

$192,715

Previous $1.76 Million 87.62%

% of portfolio

0.03%

Previous 0.24%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$111.15 - $128.97 $1.37 Million - $1.59 Million	-12,305 Reduced 86.47%	1,926 $218,000
Q2 2024 Aug 08, 2024	SELL	$123.8 - $132.96 $73,042 - $78,446	-590 Reduced 3.98%	14,231 $1.76 Million
Q1 2024 May 01, 2024	SELL	$113.24 - $131.95 $93,196 - $108,594	-823 Reduced 5.26%	14,821 $1.96 Million
Q4 2023 Mar 05, 2024	BUY	$100.18 - $109.02 $182,628 - $198,743	1,823 Added 13.19%	15,644 $1.71 Million
Q3 2023 Oct 18, 2023	BUY	$102.95 - $114.33 $11,324 - $12,576	110 Added 0.8%	13,821 $1.42 Million
Q2 2023 Aug 07, 2023	SELL	$108.61 - $118.38 $64,840 - $70,672	-597 Reduced 4.17%	13,711 $1.58 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $44,675 - $49,849	-434 Reduced 2.94%	14,308 $1.52 Million
Q4 2022 Jan 26, 2023	BUY	$87.44 - $112.11 $28,155 - $36,099	322 Added 2.23%	14,742 $0
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $39,729 - $44,631	470 Added 3.37%	14,420 $1.24 Million
Q2 2022 Aug 10, 2022	BUY	$83.49 - $94.64 $1.06 Million - $1.2 Million	12,668 Added 988.14%	13,950 $1.27 Million
Q1 2022 May 10, 2022	SELL	$73.51 - $82.4 $727,381 - $815,348	-9,895 Reduced 88.53%	1,282 $105,000
Q4 2021 Feb 03, 2022	BUY	$72.28 - $90.54 $130,393 - $163,334	1,804 Added 19.25%	11,177 $856,000
Q3 2021 Oct 27, 2021	BUY	$71.68 - $78.83 $671,856 - $738,873	9,373 New	9,373 $704,000
Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $4.21 Million - $4.96 Million	-61,200 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$71.77 - $79.65 $64,808 - $71,923	903 Added 1.5%	61,200 $5.01 Million
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $365,680 - $414,501	4,997 Added 9.04%	60,297 $5 Million
Q2 2020 Aug 12, 2020	BUY	$70.42 - $80.13 $95,137 - $108,255	1,351 Added 2.5%	55,300 $4.28 Million
Q1 2020 May 12, 2020	SELL	$63.36 - $87.82 $1.15 Million - $1.59 Million	-18,073 Reduced 25.09%	53,949 $4.15 Million
Q4 2019 Feb 12, 2020	SELL	$77.58 - $87.54 $52,676 - $59,439	-679 Reduced 0.93%	72,022 $6.25 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $413,799 - $451,056	5,439 Added 8.09%	72,701 $6.12 Million
Q3 2019 Nov 12, 2019	SELL	$76.08 - $82.93 $89,394 - $97,442	-1,175 Reduced 1.72%	67,262 $5.64 Million
Q2 2019 Aug 13, 2019	BUY	$69.84 - $81.59 $4.78 Million - $5.58 Million	68,437 New	68,437 $5.74 Million

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.

Account

Greenwood Capital Associates LLC Merck & Co., Inc. Transaction History